Verrica Pharmaceuticals Inc. Insider Trading

VRCA

Cluster buy

4 insiders bought 211K of their own stock in 2 days.

Open-market purchases by executives and directors between Aug 17 and Aug 18. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market

+$18.2M

9 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

5 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 18, 2026

Get an email when VRCA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 17 – 18	Noah L. Rosenberg CMO	Bought 2 parts	6,230	$4.91 average	31K	264%	Form 4
Aug 18	John J. Kirby Interim CFO	Bought	5,000	$4.93	25K	26%	Form 4
Aug 17	David Zawitz Chief Operating Officer	Bought	6,000	$4.98	30K	29%	Form 4
Aug 14 – 17	Jayson Rieger CEO and President	Bought 2 parts	25,000	$5.03 average	126K	14%	Form 4
Nov 25, 2025	David Zawitz Chief Operating Officer	Bought	10,000	$4.24	42K	91%	Form 4
Nov 25, 2025	Jayson Rieger CEO and President	Bought	94,311	$4.24	400K	107%	Form 4
Nov 25, 2025	Noah L. Rosenberg CMO	Bought	2,357	$4.24	10K	New	Form 4
Nov 25, 2025	John J. Kirby Interim CFO	Bought	3,536	$4.24	15K	65%	Form 4
Nov 25, 2025	Paul B Manning Director	Bought 2 parts	4,126,142	$4.24 average	$17.5M	117%	Form 4
Mar 17, 2025	Christopher G. Hayes Chief Legal Officer	SoldNo plan	4,315	$0.65	3K	2.4%	Form 4
Nov 22, 2024	Jayson Rieger CEO and President	Bought	280,898	—	—	46%	Form 4
Nov 22, 2024	John A Stalfort III Director	Bought	1,123,595	—	—	150%	Form 4
Nov 22, 2024	Paul B Manning Director	Bought 2 parts	22,921,348	—	—	188%	Form 4

Aug 17 – 18
Noah L. Rosenberg
CMO · bought 6,230 at avg $4.91
31K
264% of stake
Aug 18
John J. Kirby
Interim CFO · bought 5,000 at $4.93
25K
26% of stake
Aug 17
David Zawitz
Chief Operating Officer · bought 6,000 at $4.98
30K
29% of stake
Aug 14 – 17
Jayson Rieger
CEO and President · bought 25,000 at avg $5.03
126K
14% of stake
Nov 25, 2025
David Zawitz
Chief Operating Officer · bought 10,000 at $4.24
42K
91% of stake
Nov 25, 2025
Jayson Rieger
CEO and President · bought 94,311 at $4.24
400K
107% of stake
Nov 25, 2025
Noah L. Rosenberg
CMO · bought 2,357 at $4.24
10K
New position
Nov 25, 2025
John J. Kirby
Interim CFO · bought 3,536 at $4.24
15K
65% of stake
Nov 25, 2025
Paul B Manning
Director · bought 4,126,142 at avg $4.24
$17.5M
117% of stake
Mar 17, 2025No plan
Christopher G. Hayes
Chief Legal Officer · sold 4,315 at $0.65
3K
2.4% of stake
Nov 22, 2024
Jayson Rieger
CEO and President · bought 280,898
—
46% of stake
Nov 22, 2024
John A Stalfort III
Director · bought 1,123,595
—
150% of stake
Nov 22, 2024
Paul B Manning
Director · bought 22,921,348
—
188% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VRCA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with VRCA

CompareIntrinsic value

VSTMVerastem Inc.

$9.85+0.82%40

JAGXJaguar Health, Inc.

$0.50-10.61%40

ARCTArcturus Therapeutics Holdings Inc.

$10.87+13.94%13

CUECue Biopharma, Inc.

$19.84-4.89%40

STOKStoke Therapeutics Inc.

$27.45+1.70%25

ZOMDFZomedica Corp.

$0.09-1.08%46

ZYBTZhengye Biotechnology Holding Ltd.

$1.37+2.24%9

SBFMSunshine Biopharma Inc.

$2.65-3.28%40

Spot a number that looks wrong? Check it in VRCA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VRCA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.